Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Long-term use of salmeterol for exercise-induced asthma results in decreased duration of action

July 22, 1998

FR-167653 attenuates ischemia-reperfusion injury to the lung in rat model

July 20, 1998

PathoGenesis completes patient enrollment in phase II TOBI trial

July 20, 1998

Singulair introduced in Germany for asthma

July 17, 1998

Yamanouchi identifies NK1 antagonist with good antiasthmatic activity

July 17, 1998

Zyrtec registered in Japan, launch scheduled for September

July 14, 1998

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

U.S. patent issues for second product in PathoGenesis' pipeline

July 7, 1998

Bio-Technology General's OxSODrol study being continued with revised endpoints

July 6, 1998

Approvable letter issued for Xopenex

July 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...